OTCMKTS:XSNX NovAccess Global - XSNX Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding NovAccess Global Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $0.24 +0.07 (+39.41%) (As of 03/17/2023 08:55 PM ET) Add Compare Share Share Today's Range$0.17▼$0.2450-Day Range$0.14▼$0.2552-Week Range$0.10▼$0.60Volume17,100 shsAverage Volume8,707 shsMarket Capitalization$4.97 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileChartCompetitorsFinancialsHeadlinesSEC FilingsShort Interest About NovAccess Global (OTCMKTS:XSNX) StockNovAccess Global, Inc. is a biopharmaceutical company, which engages in the provision of diagnostics, therapeutics in cancer, and neurological diseases and the development of immunotherapies to treat brain tumor patients. The company was founded on February 25, 1997 and is headquartered in Cuyahoga County, OH.Read More Receive XSNX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for NovAccess Global and its competitors with MarketBeat's FREE daily newsletter. Email Address XSNX Stock News HeadlinesMarch 15, 2023 | finanznachrichten.deNovAccess Global Inc.: Dr. Christopher Wheeler, NovAccess Lead Scientist, Receives Prestigious Golden Axon AwardMarch 15, 2023 | finance.yahoo.comDr. Christopher Wheeler, NovAccess Lead Scientist, Receives Prestigious Golden Axon AwardMarch 20, 2023 | Stansberry Research (Ad)The gold catalyst we’ve waited forIf you thought the SVB meltdown was bad… watch out. Because even bigger red flag just appeared. This signal proves that a recession is likely right around the corner. It will take most by surprise. Stocks will crash. Millions will go jobless, and lose their homes. But there is ONE important step you should take today to make sure you come out the other side OK. February 16, 2023 | finanznachrichten.deNovAccess Global Inc.: NovAccess Global to Present at World Orphan Drug CongressFebruary 16, 2023 | finance.yahoo.comNovAccess Global to Present at World Orphan Drug CongressFebruary 3, 2023 | finanznachrichten.deNovAccess Global Inc.: NovAccess Global Leadership to Present at World Brain Mapping Foundation Annual CongressFebruary 3, 2023 | finance.yahoo.comNovAccess Global Leadership to Present at World Brain Mapping Foundation Annual CongressJanuary 5, 2023 | finance.yahoo.comNovAccess Global Announces Fireside Chat with Dr. Christopher Wheeler, the Company’s Lead Scientist and President of its StemVax Therapeutics DivisionMarch 20, 2023 | Oxford Club (Ad)My No. 1 dividend stock for a LIFETIME of income.Few people realize this… But dividends account for up to 90% of the stock market's returns over the past century! I think it's a crying shame folks don't know how powerful dividends are.November 22, 2022 | finanznachrichten.deNovAccess Global Inc.: NovAccess Global Announces Initial Fireside Chat with Glioblastoma Patient AdvocateNovember 22, 2022 | finance.yahoo.comNovAccess Global Announces Initial Fireside Chat with Glioblastoma Patient AdvocateNovember 10, 2022 | finanznachrichten.deNovAccess Global Inc.: NovAccess Global Appoints Healthcare IP Consultant Dr. Peter Weinstein to Scientific Advisory BoardNovember 10, 2022 | finance.yahoo.comNovAccess Global Appoints Healthcare IP Consultant Dr. Peter Weinstein to Scientific Advisory BoardNovember 8, 2022 | finance.yahoo.comNovAccess Global Announces Virtual Annual Shareholders' MeetingOctober 26, 2022 | finance.yahoo.comNovAccess Global Receives FDA Approval of Orphan Drug Application for TLR-AD1October 20, 2022 | finanznachrichten.deNovAccess Global Inc.: NovAccess Global Announces Fireside Chat with Board Member PerspectivesOctober 20, 2022 | finance.yahoo.comNovAccess Global Announces Fireside Chat with Board Member PerspectivesOctober 1, 2022 | finanznachrichten.deDarrow Associates, Inc.: NovAccess Global Announces Fireside Chat Series for the Investment CommunitySeptember 30, 2022 | seekingalpha.comXSNX NovAccess Global Inc.September 30, 2022 | seekingalpha.comXSNX NovAccess Global Inc.September 29, 2022 | finance.yahoo.comNovAccess Global Announces Fireside Chat Series for the Investment CommunitySeptember 23, 2022 | finanznachrichten.deNovAccess Global Inc.: NovAccess Global Announces Effectiveness of Form S-1 Registration StatementSeptember 22, 2022 | finance.yahoo.comNovAccess Global Announces Effectiveness of Form S-1 Registration StatementSeptember 6, 2022 | reuters.comNovAccess Global IncAugust 10, 2022 | finanznachrichten.deNovAccess Global Inc.: NovAccess Global Announces Uplisting to OTCQBAugust 10, 2022 | finance.yahoo.comNovAccess Global Announces Uplisting to OTCQBJuly 19, 2022 | finance.yahoo.comCORRECTION: NovAccess Global Announces Filing of Orphan Drug Application for TLR-AD1See More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive XSNX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for NovAccess Global and its competitors with MarketBeat's FREE daily newsletter. Email Address XSNX Company Calendar Today3/20/2023Fiscal Year End9/30/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS Industry Pharmaceutical preparations Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:XSNX CUSIPN/A CIK1039466 Webwww.xsunx.com Phone(213) 642-9268Fax949-266-5823Employees2Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-1,720,000.00 Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on Assets-3,684.31% Debt Debt-to-Equity RatioN/A Current Ratio0.01 Quick Ratio0.01 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value($0.50) per share Price / Book-0.47Miscellaneous Outstanding Shares20,980,000Free Float20,674,000Market Cap$4.97 million OptionableNot Optionable Beta1.63 Key ExecutivesDwain Morris-IrvinChief Executive OfficerNeil J. LairdChief Financial OfficerKey CompetitorsBellicum PharmaceuticalsNASDAQ:BLCMEnveric BiosciencesNASDAQ:ENVBInMed PharmaceuticalsNASDAQ:INMHistogenNASDAQ:HSTONemus BioscienceOTCMKTS:NMUSView All Competitors XSNX Stock - Frequently Asked Questions How have XSNX shares performed in 2023? NovAccess Global's stock was trading at $0.29 on January 1st, 2023. Since then, XSNX stock has decreased by 18.3% and is now trading at $0.2370. View the best growth stocks for 2023 here. Are investors shorting NovAccess Global? NovAccess Global saw a decrease in short interest in the month of February. As of February 28th, there was short interest totaling 3,600 shares, a decrease of 52.6% from the February 13th total of 7,600 shares. Based on an average trading volume of 6,200 shares, the days-to-cover ratio is presently 0.6 days. View NovAccess Global's Short Interest. What other stocks do shareholders of NovAccess Global own? Based on aggregate information from My MarketBeat watchlists, some companies that other NovAccess Global investors own include Co-Diagnostics (CODX), iBio (IBIO), PharmaCyte Biotech (PMCB), SANUWAVE Health (SNWV), Sierra Oncology (SRRA), Tonix Pharmaceuticals (TNXP), T2 Biosystems (TTOO), Kopin (KOPN), Ascent Solar Technologies (ASTI) and BioRestorative Therapies (BRTX). What is NovAccess Global's stock symbol? NovAccess Global trades on the OTCMKTS under the ticker symbol "XSNX." How do I buy shares of NovAccess Global? Shares of XSNX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is NovAccess Global's stock price today? One share of XSNX stock can currently be purchased for approximately $0.24. How much money does NovAccess Global make? NovAccess Global (OTCMKTS:XSNX) has a market capitalization of $4.97 million. How can I contact NovAccess Global? NovAccess Global's mailing address is 8834 MAYFIELD RD, CHESTERLAND OH, 44026. The official website for the company is www.xsunx.com. The company can be reached via phone at (213) 642-9268, via email at investors@xsunx.com, or via fax at 949-266-5823. This page (OTCMKTS:XSNX) was last updated on 3/20/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.